Name: NeuroPace, Inc. (NPCE) Financial Statements
Creator: FinSpry

NeuroPace Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

NeuroPace, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	79.91	65.42	45.52	45.18	41.14
Cost of Revenue	20.82	17.30	13.03	11.75	10.87
Gross Profit	59.09	48.12	32.49	33.44	30.27
Operating Expenses
Research & Development	23.65	20.78	21.95	18.21	15.70
Selling, General & Administrative	57.10	54.52	51.34	38.96	27.63
Operating Expenses	80.76	75.30	73.29	57.17	43.32
Operating Income	-21.67	-27.17	-40.79	-23.74	-13.05
Other Income/Expense
Interest Income	3.02	3.05	1.58	0.45	0.04
Interest Expense	8.80	-8.52	-7.53	7.41	-11.49
Other Income/Expense	0.30	-0.32	-0.34	5.38	0.22
Income
Income Before Tax	-27.14	-32.96	-47.08	-36.08	-24.28
Income Tax Expense	0.00	0.00	0.00	0.00	0.00
Net Income	-27.14	-32.96	-47.08	-36.08	-24.28
Net Income - Continuous Operations	-27.14	-32.96	-47.08	-36.08	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-16.57	-27.00	-36.57	-28.10	-12.74
EBIT	-18.34	-27.17	-39.55	-28.67	-13.05
Depreciation & Amortization	1.77	0.17	0.27	0.30	0.31
Earnings Per Share
Basic EPS	-1.00	-1.00	-2.00	-2.00	-118.00
Diluted EPS	-1.00	-1.00	-2.00	-2.00	-118.00
Basic Shares Outstanding	29.13	25.85	24.59	16.61	0.20
Diluted Shares Outstanding	29.13	25.85	24.59	16.61	0.20